EGFR and non-small cell lung carcinoma: Serum CYFRA 21-1 level may be a predictive factor for patients with NSCLC treated with EGFR-TKIs, regardless of EGFR mutation status.Elevated serum CYFRA 21-1 was associated with shorter PFS and OS of patients with NSCLC treated with EGFR-TKI.